Medroxyprogesterone Acetate Injection Pharmacology

Medroxyprogesterone acetate, commonly known as Depo-Provera, functions as a progestin-only injectable contraceptive administered every three months. By inhibiting gonadotropin release from the pituitary, it effectively prevents ovulation. While it offers a convenient alternative to daily regimens, patients often experience unpredictable bleeding or spotting during the initial months, eventually leading to amenorrhea. Long-term use carries a boxed warning regarding potential loss of bone mineral density, necessitating adequate calcium and vitamin D intake. Crucially, this method provides no protection against sexually transmitted diseases. Clinicians must monitor for drug interactions, particularly with enzyme inducers like carbamazepine or rifampin, which can lower drug concentrations and increase pregnancy risk. Additionally, caution is advised for patients on anticoagulants due to a potential increase in thromboembolic risk.